This model is attractive because it integrates hallmark pathologies such as pTau, Aβ, ApoJ and ApoE, with emerging AD pathologies such as Reelin, Dab1, and ApoER2 into a coherent model. The gene discussed is CLU; the disease is Alzheimer disease.